Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: debra vogt who wrote (39466)	5/11/1999 8:07:00 PM
From: Adelle	Respond to of 120523

debra, From experience, these bio-techs are for the LOOOOOOOOOOOOOOOONG term portfolio if ever bought. I bought a few in '97, recommended by Mike Murphy's Letter, and ended up selling them over time, some at a loss and some even, some with a gain. (VICL, TRGA,INSV, SUGN, also of his recs.-ROSS, SEEQ.) If you catch one on a spike due to a news flash its good to grab the profit...they always drop back down to oblivion. Actually, SUGN and VICL have more gain potential than others of his that I know of. GERON was actually a good one we had...took profits when it spiked last year with its cancer cell announcement. In other words, patience are needed with these..but watch it for a chance to take profits.